Objective The autoimmune mechanism is considered to play an important role in the development of acquired idiopathic generalized anhidrosis (AIGA), and muscarinic M3 receptors (M3Rs) on eccrine glands are possible autoimmune targets. We investigated the existence of autoantibodies against M3Rs in AIGA patients. Methods We immunostained M3R-expressing cultured cells with the serum of 12 AIGA patients (mean age: 35.0±11.7 years, mean disease duration: 26.6±25.8 months) and 10 healthy subjects (mean age: 32.4± 10.4 years). Results The surface of the M3R-expressing cells was stained by the serum obtained from one of the 12 AIGA patients but not by the serum obtained from the remaining 11 patients or healthy subjects. Conclusion The presence of M3R autoantibodies may therefore be related to the underlying mechanism of disease in a subset of AIGA patients.
Introduction
Acquired anhidrosis is caused by various conditions, including neurological, endocrinological and metabolic abnormalities (1) , and is classified into idiopathic and secondary anhidrosis. Acquired generalized anhidrosis is associated with several systemic diseases, such as Sjögren's syndrome and Fabry disease. Meanwhile, acquired idiopathic generalized anhidrosis (AIGA) is characterized by anhidrosis or hypohidrosis of the whole body with no identified cause or other autonomic or neurological abnormalities (2) . In addition, AIGA is often associated with cholinergic urticaria and is also known as "cholinergic urticaria associated acquired generalized hypohidrosis" (3) . Steroid therapy has been reported to be effective for AIGA (2) (3) (4) (5) (6) and may be associated with other autoimmune diseases (7) , thus implying that the autoimmunological background of AIGA is related to its pathogenesis. In most AIGA patients, skin biopsies show no remarkable abnormalities in the eccrine glands or postganglionic sudomotor nerve fibers, except for nonspecific lymphocyte infiltration around the eccrine glands (2-6) and reduced muscarinic M3 receptors (M3Rs) on the eccrine glands (6) . These findings suggest that a dysfunction and/or the signal transduction of M3Rs on eccrine glands may thus be key factors in the pathogenesis of AIGA. Therefore, antibodies against M3Rs may be a candidate for the developmental mechanism underlying the pathogenesis of AIGA; however, there have been no reports on the presence of M3R autoantibodies in patients with AIGA. Therefore, we investigated the existence of M3R autoantibodies in AIGA patients. a) The thermoregulatory sweat test was performed for 10min in a sauna room at a temperature of 70 degrees; b) 0.5mL of 0.5 % acetylcholine was intradermally injected; c) Sympathetic sweat responses (SSwRs), which are an index of emotional sweating, were recorded during deep breathing, mental arithmetic and isotonic exercise; d) The head-up tilt test was performed to identify orthostatic hypotension; e) We used the coefficient of R-R interval variation as an index of heart rate variability; f) Skin vasomotor reflexes (SkVR) were recorded on the palm during deep breathing, mental arithmetic and isotonic exercise; g) Except for case 9, steroid pulse therapy and subsequent oral prednisolone were administrated. Orthostatic hypotension was defined by consensus as a fall in blood pressure of at least 20 mmHg systolic or 10 mmHg diastolic within 3min in the upright position. Normal ranges in other autonomic function tests were based on our laboratory data (not shown).
sweating) were preserved in all patients. The intradermal injection of 5 % acetylcholine evoked sweating in none of the 11 examined patients. A skin biopsy was performed in all AIGA patients, and no morphological abnormalities were observed in the sweat glands in any of the patients, except for the patient in Case 10 who had swollen secretion cells, whereas lymphocyte infiltration around the sweat glands was seen in seven (58%) patients (Table) . The full length of human M3R (Accession No. NM_ 000740) was amplified from human fetal brain total RNA using reverse transcription polymerase chain reaction (Clontech). The cloned M3R was confirmed based on the DNA sequence and ligated to a pcDNA4 HisMax expression vector (Invitrogen). The M3R recombinant expression vector and the vector for negative controls were each transfected into Chinese hamster ovarian (CHO) cell lines. Each CHO transfectant was selected using Zeocin TM (Invitrogen). The stable CHO cell lines transfected by M3R (CHO-M3R) and the vector only (MOCK) were analyzed using immunoblotting and cell staining with two kinds of antibodies against M3Rs: one type recognizes the extracellular domain (Millipore, AB9018) and the other recognizes the intracellular domain (Sigma, M0194). Immunoblotting was performed using the standard method. Cell staining using CHO-M3R and MOCK for M3Rs and the serum from the patients and healthy volunteers was performed using a 16-well slide chamber (Thermoscientific). After the chamber was fixed with equal volumes of methanol and acetone, it was incubated with diluted serum for one hour at room temperature. After being washed with phosphate buffered saline (PBS) several times, the chamber was incubated with Alexa Fluor 488 goat anti-human IgG (Invitrogen, A11013) for one hour at room temperature. Likewise, after being washed several times with PBS, the chamber was incubated with M3R antibodies (Sigma, M0194 or Millipore, AB9018) for one hour at room temperature, followed by incubation with secondary rabbit antibodies conjugated with tetramethylrhodamine-5-(and 6)-isothiocyanate (Beckman-coulter) for one hour at room temperature. Finally, the chamber was mounted with Vectashield (Vector Laboratories, Inc.).
The ethics committees of Shinshu University and the Chiba University School of Medicine approved the study protocol and all procedures.
Results

Autoantibody assay
Immunoblotting was performed using the standard method. The CHO-M3R cell lines were immunostained with antibodies against the extracellular and intracellular domains, while the MOCK cell lines were not (Fig. 1) . CHO-M3R cell staining using the patient serum and M3R antibodies showed that the serum of the patient in Case 11 merged with the M3R antibodies at the cell surface (Fig. 2) . There was no significant staining in the MOCK cells using the serum and M3R antibodies (data not shown). The remaining 11 patients and all 10 healthy volunteers did not show any significant staining in the CHO-M3R or MOCK cells.
A clinical report of a patient with anti-M3R antibodies
A 55-year-old man (Case 11) noticed generalized anhidrosis. He experienced hot flashes and dizziness in hot environments. He had no history of either dry mouth, dry eyes, concomitant pain or urticaria. His condition gradually deteriorated and he was admitted to a hospital six months after the onset of symptoms. A physical examination revealed normal findings, except for generalized dry skin. The findings of a routine blood examination and the levels of serum IgG, IgA, IgM and IgE were normal, as was the patient's thyroid function. Antinuclear, anti-Ro/SSA and anti-La/SSB antibodies were negative. A thermoregulatory sweat test using a sauna bath (70 for 10 minutes) demonstrated anhidrosis on the whole body, except for the right temple; however, no cholinergic urticaria was found. The intradermal injection of acetylcholine (5%, 0.05 mL) did not elicit sweating in the areas of anhidrosis. However, the sympathetic sweat response on the palm (emotional sweating) (8) was preserved. Cardiovascular autonomic function tests showed normal results (Table) . The patient had bilaterally normal Schirmer's test findings (right: 25 mm, left: 25 mm) and normal salivary secretion on a gum test (10 mL/min). A skin biopsy of an anhidrosis site showed normal eccrine glands surrounded by mild lymphocyte infiltration. The patient was treated with intravenous methylprednisolone (1 g/ day for three days, two courses) followed by oral prednisolone (50 mg/alternate days); however, no significant improvements were observed. After two months, he developed hyperglycemia; therefore, we discontinued the treatment with oral prednisolone.
Discussion
Of the 12 AIGA patients, only one exhibited M3R autoantibodies in his serum. That patient presented with generalized anhidrosis without other autonomic or neurological abnormalities and showed no response to the intradermal injection of acetylcholine, with normal eccrine glands with mild lymphocyte infiltration and preserved emotional sweating. These clinical features are typical of AIGA (2-6). On the other hand, AIGA is characterized by a young age at onset, responsiveness to steroids and cholinergic urticaria (2-6). However, the patient's age at the onset of anhidrosis was higher (55 years) than is typical for AIGA, and he had no cholinergic urticaria, with a poor response to steroids. These clinical features are atypical for AIGA. Meanwhile, the remaining 11 patients showed no significant M3R autoantibodies. The negative results for M3R autoantibodies observed in these patients may be caused by technical limitations, such as the sensitivity of the test. Alternatively, M3R autoantibodies may be detected in only certain AIGA patients because AIGA is likely a heterogeneous disorder with several etiologies.
M3Rs are expressed in exocrine glands (e.g., salivary glands, lachrymal glands and eccrine glands). M3R autoantibodies have been reported to be detected in patients with Sjögren's syndrome [at a rate ranging from 11 to 90% (9, 10)], an autoimmune disease characterized by the infiltration of lymphocytes, mainly T-cells, into the lachrymal and salivary glands, thus resulting in dry eyes and mouth. In patients with Sjögren's syndrome, the infiltration of T-cells may also be found around eccrine glands (11) . Tcell infiltration around eccrine glands is also seen in patients with AIGA (12) . AIGA and Sjögren's syndrome may have a similar etiological background. However, there are several differences between AIGA and Sjögren's syndrome with respect to their clinical and pathological features: (i) most AIGA patients are men, whereas most patients with Sjögren's syndrome are women; (ii) unlike AIGA, Sjögren's syndrome is associated with the involvement of several body parts, including the arthroses, lungs, kidneys, thyroid, liver and nervous system; and (iii) CD3-positive cells have been reported to be dominant in lymphocytes infiltrating the eccrine glands in AIGA patients, whereas CD4-positive cells are dominant in lymphocytes infiltrating the exocrine glands in patients with Sjögren's syndrome (12) .
It is not certain whether M3R autoantibodies participated in the development of anhidrosis in our patient (Case 11), and evidence has not yet been found to show that M3R antibodies suppress the function of eccrine glands in patients with AIGA. Meanwhile, in patients with Sjögren's syndrome, M3R autoantibodies are considered to play a crucial role in the pathogenesis of sialadenitis and dacryoadenitis. Antibodies against M3Rs interfere with the production of saliva and tears (13) , and M3R-reactive T-cells have been identified in the peripheral blood of half of all patients with Sjögren's syndrome (14) . Although, to our knowledge, there have been no studies of the effects of autoantibodies against M3Rs on sweat production or any investigations of the role of M3R-reactive T-cells in AIGA patients, there is a possibility that M3R autoantibodies participate in the pathophysiology of anhidrosis in a subset of AIGA patients.
Emotional sweating on the palm was preserved in our AIGA patient with M3R autoantibodies. Spared palm sweating in patients with AIGA has been described in a previous report (2) and may be a characteristic of AIGA. However, M 3Rs exist on eccrine glands in the glabrous palm skin as well as hairy skin. The palm skin, which has a high density of eccrine glands (300/cm 2 ) compared with other body areas (65-120/cm 2 ) (15), may have enough ability to sweat despite an interruption due to M3R autoantibodies.
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